Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11812669 | 0.73 | CYP2C19 (0.45) | MEN1NPC1KMT2ATNKS2CYP2C19 | |
| SCHEMBL18125709 | 0.73 | CYP2C19 (0.45) | MEN1NPC1KMT2ATNKS2CYP2C19 | |
| SCHEMBL1316915 | 0.73 | MEN1 (0.44) | MEN1NPC1KMT2ATNKS2CYP2C19 | |
| SCHEMBL15604879 | 0.73 | — | — | |
| SCHEMBL18676170 | 0.70 | NOS2 (0.39) | CYP2C19TSHRCYP1A2CYP2D6CYP2C9 | |
| SCHEMBL6844725 | 0.69 | TNKS2 (0.45) | MEN1NPC1KMT2ATNKS2CYP2C19 | |
| SCHEMBL15604897 | 0.69 | CYP2C19 (0.42) | MEN1NPC1KMT2ATNKS2CYP2C19 | |
| SCHEMBL17433168 | 0.69 | MEN1 (0.41) | MEN1NPC1KMT2ATNKS2CYP2C19 | |
| SCHEMBL22889194 | 0.69 | KMT2A (0.47) | MEN1NPC1KMT2ATNKS2CYP2C19 | |
| SCHEMBL20746846 | 0.68 | HDAC4 (0.38) | NPC1TNKS2TSHRALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2962991-B1 | METHOD FOR PRODUCING CARBON MATERIAL | NISSHINBO HOLDINGS INC (JP) | 2019-09-18 | — | — | EP | disclosed |
| EP-2962991-A1 | CARBON MATERIAL, FUEL CELL, ELECTRICAL DOUBLE-LAYER CAPACITOR, CARBON DIOXIDE ADSORPTION DEVICE, AND CARBON MATERIAL PRODUCTION METHOD | Nisshinbo Holdings Inc. (JP) | 2016-01-06 | — | — | EP | disclosed |
| US-20070191336-A1 | p38 kinase inhibitors | DECIPHERA PHARMACEUTICALS, LLC | 2007-08-16 | — | — | US | disclosed |
| US-20070191336-A1 | p38 kinase inhibitors | DECIPHERA PHARMACEUTICALS, LLC | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191336-A1 | p38 kinase inhibitors | MAPK1, MAP3K8, MAP3K1 | MEN1 4811/4885NPC1 4635/4885KMT2A 3389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.